These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12694322)

  • 1. Dialysis modalities and dyslipidemia.
    Attman PO; Samuelsson O; Johansson AC; Moberly JB; Alaupovic P
    Kidney Int Suppl; 2003 May; (84):S110-2. PubMed ID: 12694322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and classification of dyslipidemia in renal disease.
    Attman PO; Samuelsson O; Alaupovic P
    Blood Purif; 1996; 14(1):49-57. PubMed ID: 8718566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbed lipoprotein composition in non-dialyzed, hemodialysis, continuous ambulatory peritoneal dialysis and post-transplant patients with chronic renal failure.
    Kimak E; Ksiazek A; Solski J
    Clin Chem Lab Med; 2006; 44(1):64-9. PubMed ID: 16375588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein metabolism and renal failure.
    Attman PO; Samuelsson O; Alaupovic P
    Am J Kidney Dis; 1993 Jun; 21(6):573-92. PubMed ID: 8503411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis removes apolipoprotein C-I, improving very low-density lipoprotein clearance.
    Kaysen GA
    Kidney Int; 2007 Oct; 72(7):779-81. PubMed ID: 17882238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of dyslipidemia in end-stage renal disease.
    Prichard SS
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S315-20. PubMed ID: 12939388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoprotein patterns in patients receiving dialysis therapy for chronic renal failure.
    Cramp DG; Tickner TR; Varghese Z; Beale DJ; Moorhead JF; Wills MR
    Clin Chim Acta; 1977 Apr; 76(2):233-6. PubMed ID: 862197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis.
    Cattran DC; Fenton SS; Wilson DR; Steiner G
    Ann Intern Med; 1976 Jul; 85(1):29-33. PubMed ID: 937920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do high-flux dialysis membranes affect renal dyslipidemia?
    Ottosson P; Attman PO; Knight C; Samuelsson O; Weiss L; Alaupovic P
    ASAIO J; 2001; 47(3):229-34. PubMed ID: 11374763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased lipoprotein-remnant formation in chronic renal failure.
    Nestel PJ; Fidge NH; Tan MH
    N Engl J Med; 1982 Aug; 307(6):329-33. PubMed ID: 7088097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
    Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of decreasing renal function on lipoprotein profiles.
    Attman PO; Samuelsson O; Alaupovic P
    Nephrol Dial Transplant; 2011 Aug; 26(8):2572-5. PubMed ID: 21220758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hyperlipidemia in patients on peritoneal dialysis: current approaches.
    Prichard SS
    Kidney Int Suppl; 2006 Nov; (103):S115-7. PubMed ID: 17080100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.